|
|
|
salicylic acid derivatives |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
sialagogues |
|
|
|
Sodium-glucose cotransporter 1 (SGLT1) inhibitors |
|
|
|
Sodium-Hydrogen Exchanger 3 inhibitors |
|
|
|
sclerostin inhibitors |
|
selectin inhibitors |
|
Sodium channel blockers |
|
|
|
|
|
|
|
substrate reduction therapy |
|
|
|
|
|
sympathomimetics |
|
synthetic vitamin d3 analogues |
|
steroids |
|
survival of motor neuron 2 splicing modifiers |
|
synthetic BH4 |
